CLINICAL_TRIALS
research
· 2026-04-21
Clinical Trial Update: Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2) [Phase 2]
Summary
Phase II randomized-registry embedded study evaluating lymphoscintigraphy to guide nodal treatment for patients with oropharyngeal cancer undergoing robotic sur…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Oropharyngeal Neoplasms, Robotic Surgery and/or Radiotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING